{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:01:02Z","timestamp":1789398062834,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21AI185460-01A1"],"award-info":[{"award-number":["1R21AI185460-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016678","name":"Margaret Q Landenberger Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016678","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jpet.2026.104899","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:28:16Z","timestamp":1777073296000},"page":"104899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synergistic immunomodulatory combinations induce robust human tolerogenic dendritic cells for antigen-specific regulatory T cell generation"],"prefix":"10.1016","volume":"393","author":[{"given":"Sihan","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0222-5636","authenticated-orcid":false,"given":"Joshua","family":"Mell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2208-0174","authenticated-orcid":false,"given":"Peter","family":"Deak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2026.104899_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/jimr\/5006201","article-title":"Immune tolerance regulation is critical to immune homeostasis","volume":"2025","author":"Han","year":"2025","journal-title":"J Immunol Res"},{"issue":"4","key":"10.1016\/j.jpet.2026.104899_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/intimm\/dxw010","article-title":"Introduction: autoimmunity special issue","volume":"28","author":"Yamamoto","year":"2016","journal-title":"Int Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fimmu.2020.00472","article-title":"The emerging jamboree of transformative therapies for autoimmune diseases","volume":"11","author":"Carballido","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-bioeng-110315-020137","article-title":"Immune tolerance for autoimmune disease and cell transplantation","volume":"18","author":"Luo","year":"2016","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.jpet.2026.104899_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of Treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.750542","article-title":"Regulatory T cells: regulation of identity and function","volume":"12","author":"Grover","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104899_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1158\/2326-6066.CIR-13-0102","article-title":"Dendritic cells: master regulators of the immune response","volume":"1","author":"Mellman","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jpet.2026.104899_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/08916931003782148","article-title":"The regulatory role of dendritic cells in the induction and maintenance of T-cell tolerance","volume":"44","author":"Zanoni","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jpet.2026.104899_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3389\/fimmu.2018.00350","article-title":"Mechanisms of tolerance induction by dendritic cells in vivo","volume":"9","author":"Hasegawa","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib10","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/cells8101291","article-title":"Current paradigms of tolerogenic dendritic cells and clinical implications for systemic lupus erythematosus","volume":"8","author":"Ritprajak","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.jpet.2026.104899_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.autrev.2013.09.008","article-title":"Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?","volume":"13","author":"Van Brussel","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jpet.2026.104899_bib12","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3389\/fimmu.2017.01764","article-title":"Tolerance through education: how tolerogenic dendritic cells shape immunity","volume":"8","author":"Domogalla","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fimmu.2018.00253","article-title":"Phosphatidylserine-liposomes promote tolerogenic features on dendritic cells in human type 1 diabetes by apoptotic mimicry","volume":"9","author":"Rodriguez-Fernandez","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41577-023-00970-x","article-title":"Therapeutic induction of antigen-specific immune tolerance","volume":"24","author":"Kenison","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib15","article-title":"A simple and efficient method for testing immunomodulatory agents for generation of tolerogenic dendritic cells from human CD14+ monocytes","volume":"218","author":"Jia","year":"2025","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jpet.2026.104899_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2011.11.011","article-title":"IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction\u2014a comparative study of human clinical-applicable DC","volume":"142","author":"Boks","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltad012","article-title":"Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration","volume":"3","author":"Mansilla","year":"2023","journal-title":"Immunother Adv"},{"key":"10.1016\/j.jpet.2026.104899_bib18","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.0902133","article-title":"Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells","volume":"184","author":"Torres-Aguilar","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fimmu.2013.00113","article-title":"Regulatory multitasking of tolerogenic dendritic cells \u2013 lessons taken from vitamin D3-treated tolerogenic dendritic cells","volume":"4","author":"Nikolic","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1203\/01.PDR.0000157677.72136.09","article-title":"Dexamethasone inhibits maturation and alters function of monocyte-derived dendritic cells from cord blood","volume":"58","author":"Mainali","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jpet.2026.104899_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10875-010-9430-5","article-title":"IL-10\/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector\/memory T cells from type 1 diabetic individuals","volume":"30","author":"Torres-Aguilar","year":"2010","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104899_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33248-7","article-title":"Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin","volume":"8","author":"Navarro-Barriuso","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2026.104899_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.imbio.2019.05.011","article-title":"Dexamethasone turns tumor antigen-presenting cells into tolerogenic dendritic cells with T cell inhibitory functions","volume":"224","author":"Falc\u00f3n-Beas","year":"2019","journal-title":"Immunobiology"},{"issue":"21","key":"10.1016\/j.jpet.2026.104899_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178949","article-title":"Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis","volume":"134","author":"Fondelli","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpet.2026.104899_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/jimr\/2208155","article-title":"Intradermally administered retinoic acid or vitamin D3-loaded liposomes induce tolerogenic skin dendritic cells","volume":"2025","author":"Nagy","year":"2025","journal-title":"J Immunol Res"},{"issue":"26","key":"10.1016\/j.jpet.2026.104899_bib26","doi-asserted-by":"crossref","first-page":"23606","DOI":"10.1021\/acsnano.5c01226","article-title":"Tolerogenic dendritic cell- and M2 macrophage polarization-inducible hybrid nanoparticles alleviate asthma in mice","volume":"19","author":"An","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpet.2026.104899_bib27","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3389\/fimmu.2017.01279","article-title":"Clinical tolerogenic dendritic cells: exploring therapeutic impact on human autoimmune disease","volume":"8","author":"Phillips","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib28","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1073\/pnas.1820039116","article-title":"Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial","volume":"116","author":"Zubizarreta","year":"2019","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"10.1016\/j.jpet.2026.104899_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110657","article-title":"TNF-\u03b1 sculpts a maturation process in vivo by pruning tolerogenic dendritic cells","volume":"39","author":"Iberg","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jpet.2026.104899_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bj.2017.01.002","article-title":"Harnessing the properties of dendritic cells in the pursuit of immunological tolerance","volume":"40","author":"Horton","year":"2017","journal-title":"Biomed J"},{"key":"10.1016\/j.jpet.2026.104899_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733231","article-title":"Transcriptomic analysis identifies a tolerogenic dendritic cell signature","volume":"12","author":"Robertson","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1298424","article-title":"High-throughput screening identification of novel immunomodulatory combinations for the generation of tolerogenic dendritic cells","volume":"10","author":"Jia","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.jpet.2026.104899_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121571","article-title":"Robust tolerogenic dendritic cells via push\/pull pairing of toll-like-receptor agonists and immunomodulators reduces EAE","volume":"286","author":"Deak","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jpet.2026.104899_bib34","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.175.7.4338","article-title":"Activation of dendritic cells via inhibition of Jak2\/STAT3 signaling","volume":"175","author":"Nefedova","year":"2005","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104899_bib35","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.jpet.2026.104899_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120911","article-title":"AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy","volume":"308","author":"de Almeida","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.jpet.2026.104899_bib37","article-title":"Mechanistic insight into RET kinase inhibitors targeting the DFG-out conformation in RET-rearranged cancer","volume":"9","author":"Plenker","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jpet.2026.104899_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/ar3329","article-title":"A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis","volume":"13","author":"Stump","year":"2011","journal-title":"Arthr Res Ther"},{"issue":"6","key":"10.1016\/j.jpet.2026.104899_bib39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ni0602-499","article-title":"Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848","volume":"3","author":"Jurk","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2017.00160","article-title":"TLR7 deficiency leads to TLR8 compensative regulation of immune response against JEV in mice","volume":"8","author":"Awais","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104899_bib41","first-page":"1270","article-title":"Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice","volume":"63","author":"Blaskovich","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpet.2026.104899_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575488","article-title":"Integrated analysis of transcriptome and secretome from umbilical cord mesenchymal stromal cells reveal new mechanisms for the modulation of inflammation and immune activation","volume":"11","author":"Cruz-Barrera","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.jpet.2026.104899_bib44","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/s42003-024-07326-8","article-title":"HSP60 controls mitochondrial ATP generation for optimal virus-specific IL-21-producing CD4 and cytotoxic CD8 memory T cell responses","volume":"7","author":"Ghahari","year":"2024","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104899_bib45","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13045-017-0459-2","article-title":"Vaccination with poly(IC:lc) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer","volume":"10","author":"Mehrotra","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jpet.2026.104899_bib46","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/eji.200425274","article-title":"Interleukin-2 is essential for CD4+CD25+ regulatory T cell function","volume":"34","author":"de la Rosa","year":"2004","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104899_bib47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/gene.2017.18","article-title":"Differential transcriptome of tolerogenic versus inflammatory dendritic cells points to modulated T1D genetic risk and enriched immune regulation","volume":"18","author":"Nikolic","year":"2017","journal-title":"Genes Immun"},{"key":"10.1016\/j.jpet.2026.104899_bib48","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.4049\/jimmunol.177.9.5868","article-title":"\u201cAlternatively activated\u201d dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig","volume":"177","author":"Lan","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104899_bib49","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-018-04567-0","article-title":"The homeobox protein VentX reverts immune suppression in the tumor microenvironment","volume":"9","author":"Le","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpet.2026.104899_bib50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/cancers13010128","article-title":"From allergy to cancer\u2014clinical usefulness of eotaxins","volume":"13","author":"Zajkowska","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jpet.2026.104899_bib51","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","article-title":"IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis","volume":"185","author":"Yan","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib52","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","article-title":"IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression","volume":"182","author":"Sadik","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jpet.2026.104899_bib53","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3390\/molecules22122151","article-title":"An overview of l-amino acid oxidase functions from bacteria to mammals: focus on the immunoregulatory phenylalanine oxidase IL4I1","volume":"22","author":"Castellano","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2026.104899_bib54","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.imbio.2008.07.026","article-title":"CD25 as an immune regulatory molecule expressed on myeloid dendritic cells","volume":"213","author":"Driesen","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.jpet.2026.104899_bib55","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.immuni.2025.06.012","article-title":"ROR\u03b3t+ dendritic cells and regulatory T cells: a couple hiding in the shadows","volume":"58","author":"Kelsall","year":"2025","journal-title":"Immunity"},{"issue":"D1","key":"10.1016\/j.jpet.2026.104899_bib56","doi-asserted-by":"crossref","first-page":"D330","DOI":"10.1093\/nar\/gky1055","article-title":"The Gene Ontology Resource: 20 years and still GOing strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.jpet.2026.104899_bib57","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The reactome pathway knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpet.2026.104899_bib58","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41556-023-01194-w","article-title":"Advances and perspectives for the human biomolecular atlas program (HuBMAP)","volume":"25","author":"Jain","year":"2023","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jpet.2026.104899_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.965303","article-title":"IL-2 and IL-15 drive intrathymic development of distinct periphery-seeding CD4+Foxp3+ regulatory T lymphocytes","volume":"13","author":"Apert","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib60","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.4049\/jimmunol.0900986","article-title":"IDO activates regulatory T cells and blocks their conversion into TH17-like T cells","volume":"183","author":"Baban","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib61","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.104899_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006728","article-title":"Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes","volume":"11","author":"Solvay","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.1016\/j.jpet.2026.104899_bib63","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.2337\/db14-1322","article-title":"Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes","volume":"64","author":"Yu","year":"2015","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jpet.2026.104899_bib64","first-page":"580","article-title":"An obligate cell-intrinsic function for CD28 in Tregs","volume":"123","author":"Zhang","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpet.2026.104899_bib65","article-title":"Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity","volume":"120","author":"Zhang","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jpet.2026.104899_bib66","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3389\/fimmu.2020.01406","article-title":"Monocyte-derived dendritic cell differentiation in inflammatory arthritis is regulated by the JAK\/STAT axis via NADPH oxidase regulation","volume":"11","author":"Marzaioli","year":"2020","journal-title":"Front Immunol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526010980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526010980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:46:57Z","timestamp":1783136817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526010980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0022356526010980"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104899","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic immunomodulatory combinations induce robust human tolerogenic dendritic cells for antigen-specific regulatory T cell generation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"104899"}}